Tapewire

Nasdaq · USD

SVRA

Savara Inc

Export transactions ↓
Tapewire entity
4900
SEC CIK
0001160308
Parsed reports
230

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 08, 2018 Filed Jun 13, 2018 00:26 UTC
Neville Robert NDirector · Chief Executive Officer
SaleCommon Stock 2,737 $12.13 $33,212.13
Disclosure

SEC source: 0000899243-18-016286 · doc4.xml · nonDerivative · entry 1

Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402,648

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.57. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
June 08, 2018 Filed Jun 13, 2018 00:26 UTC
Lowrance David LChief Financial Officer
SaleCommon Stock 675 $12.13 $8,186.60
Disclosure

SEC source: 0000899243-18-016285 · doc4.xml · nonDerivative · entry 1

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,080

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.40. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
June 08, 2018 Filed Jun 13, 2018 00:22 UTC SaleCommon Stock 2,638 $12.11 $31,949.61
Disclosure

SEC source: 0000899243-18-016282 · doc4.xml · nonDerivative · entry 1

Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,688

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.55. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 12:01 UTC
PIKOVER YURIDirector
PurchaseCommon Stock 3,734 $9.00 $33,603.01
Disclosure

SEC source: 0000899243-18-009018 · doc4.xml · nonDerivative · entry 1

PIKOVER YURI · CIK 0001032389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,734

F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $8.98 to $9.00. The purchase prices ranged from $8.98 to $9.00. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:09 UTC
Neville Robert NDirector · Chief Executive Officer
SaleCommon Stock 9,476 $13.08 $123,916.70
Disclosure

SEC source: 0000899243-18-004482 · doc4.xml · nonDerivative · entry 2

Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,385

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:09 UTC
Neville Robert NDirector · Chief Executive Officer
SaleCommon Stock 15,524 $12.84 $199,256.75
Disclosure

SEC source: 0000899243-18-004482 · doc4.xml · nonDerivative · entry 1

Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,861

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:08 UTC SaleCommon Stock 8,890 $13.05 $115,981.61
Disclosure

SEC source: 0000899243-18-004481 · doc4.xml · nonDerivative · entry 2

Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,326

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:08 UTC SaleCommon Stock 16,110 $12.75 $205,338.06
Disclosure

SEC source: 0000899243-18-004481 · doc4.xml · nonDerivative · entry 1

Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,216

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:07 UTC
Lowrance David LChief Financial Officer
SaleCommon Stock 2,064 $13.30 $27,442.74
Disclosure

SEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 4

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,755

F1 · shares: The sales reported on this Form 4 for February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 15, 2018 Filed Feb 20, 2018 11:07 UTC
Lowrance David LChief Financial Officer
SaleCommon Stock 4,936 $12.70 $62,686.71
Disclosure

SEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 3

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,819

F1 · shares: The sales reported on this Form 4 for February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.

F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.31 to $12.96.

Read SEC document
January 02, 2018 Filed Feb 20, 2018 11:07 UTC
Lowrance David LChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 31,894 $0.00 Strike: $1.51 $0.00
Disclosure

SEC source: 0000899243-18-004480 · doc4.xml · derivative · entry 5

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,684

Underlying: Common Stock · 31,894 shares

Expires 2026-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in sixteen equal quarterly installments beginning on February 1, 2017.

Read SEC document
January 02, 2018 Filed Feb 20, 2018 11:07 UTC
Lowrance David LChief Financial Officer
Tax withholdingCommon Stock 3,239 $15.06 $48,779.34
Disclosure

SEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 2

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,755

Read SEC document
January 02, 2018 Filed Feb 20, 2018 11:07 UTC
Lowrance David LChief Financial Officer
Exercise / conversionCommon Stock 31,894 $1.51 $48,159.94
Disclosure

SEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 1

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2017 Filed Dec 19, 2017 18:49 UTC
PIKOVER YURIDirector
GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $15.21 $0.00
Disclosure

SEC source: 0000899243-17-029234 · doc4.xml · derivative · entry 1

PIKOVER YURI · CIK 0001032389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-12-17

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 17, 2017 Filed Dec 20, 2017 00:02 UTC
Elam Nevan CDirector
GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $15.21 $0.00
Disclosure

SEC source: 0000899243-17-029246 · doc4.xml · derivative · entry 1

Elam Nevan C · CIK 0001314773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-12-17

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 17, 2017 Filed Dec 20, 2017 00:01 UTC GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $15.21 $0.00
Disclosure

SEC source: 0000899243-17-029244 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-12-17

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 17, 2017 Filed Dec 19, 2017 23:47 UTC GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $15.21 $0.00
Disclosure

SEC source: 0000899243-17-029233 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-12-17

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
October 27, 2017 Filed Oct 27, 2017 16:04 UTC
PIKOVER YURIDirector
PurchaseCommon Stock 50,000 $7.85 $392,500.00
Disclosure

SEC source: 0000899243-17-024810 · doc4.xml · nonDerivative · entry 1

PIKOVER YURI · CIK 0001032389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Read SEC document
June 07, 2017 Filed Jun 9, 2017 10:34 UTC
PIKOVER YURIDirector
PurchaseCommon Stock 100,000 $4.75 $475,000.00
Disclosure

SEC source: 0000899243-17-015872 · doc4.xml · nonDerivative · entry 1

PIKOVER YURI · CIK 0001032389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:38 UTC
Neville Robert NDirector · Chief Executive Officer
PurchaseCommon Stock 52,250 $4.75 $248,187.50
Disclosure

SEC source: 0000899243-17-015876 · doc4.xml · nonDerivative · entry 1

Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430,385

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:35 UTC PurchaseCommon Stock 21,000 $4.75 $99,750.00
Disclosure

SEC source: 0000899243-17-015874 · doc4.xml · nonDerivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,428

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:34 UTC PurchaseCommon Stock 10,500 $4.75 $49,875.00
Disclosure

SEC source: 0000899243-17-015871 · doc4.xml · nonDerivative · entry 1

Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,326

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:31 UTC
Lowrance David LChief Financial Officer
PurchaseCommon Stock 2,100 $4.75 $9,975.00
Disclosure

SEC source: 0000899243-17-015869 · doc4.xml · nonDerivative · entry 1

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:30 UTC PurchaseCommon Stock 52,250 $4.75 $248,187.50
Disclosure

SEC source: 0000899243-17-015868 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,866

Read SEC document
May 25, 2017 Filed May 26, 2017 22:53 UTC GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $5.13 $0.00
Disclosure

SEC source: 0000899243-17-014622 · doc4.xml · derivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-05-25

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of May 25, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
May 25, 2017 Filed May 26, 2017 22:45 UTC GrantStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $5.13 $0.00
Disclosure

SEC source: 0000899243-17-014620 · doc4.xml · derivative · entry 1

Pauls Matthew · CIK 0001573429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-05-25

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of May 25, 2017, subject to the reporting person's continued service with the Issuer.

Read SEC document
April 27, 2017 Filed Jun 19, 2019 21:58 UTC Exercise / conversionRestricted Stock Units · Derivative 1,142 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · derivative · entry 7

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017.

F3 · derivative.exercise_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.

F3 · derivative.expiration_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.

Read SEC document
April 27, 2017 Filed Jun 19, 2019 21:58 UTC Exercise / conversionCommon Stock 1,142 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.

Read SEC document
April 27, 2017 Filed Sep 16, 2020 01:45 UTC
Pauls MatthewDirector · See Remarks
Exercise / conversionRestricted Stock Units · Derivative 650 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-20-025225 · doc4.xml · derivative · entry 3

Pauls Matthew · CIK 0001573429 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 650 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The vesting of the restricted stock units ("RSUs") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.

F3 · shares: Each RSU represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017.

F4 · derivative.exercise_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.

F4 · derivative.expiration_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.

Read SEC document
April 27, 2017 Filed Sep 16, 2020 01:45 UTC
Pauls MatthewDirector · See Remarks
Exercise / conversionCommon Stock 650 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-025225 · doc4.xml · nonDerivative · entry 1

Pauls Matthew · CIK 0001573429 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The vesting of the restricted stock units ("RSUs") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.

Read SEC document
January 23, 2017 Filed Jan 23, 2017 22:16 UTC GrantRestricted Stock Units · Derivative 45,535 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005127 · doc4.xml · derivative · entry 1

Pauls Matthew · CIK 0001573429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,535

Underlying: Common Stock · 45,535 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 17:12 UTC GrantRestricted Stock Units · Derivative 63,933 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005121 · doc4.xml · derivative · entry 1

DITTRICH HOWARD · CIK 0001065156 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,933

Underlying: Common Stock · 63,933 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:09 UTC
Roberts BrandiChief Financial Officer & SVP
GrantRestricted Stock Units · Derivative 889,926 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005113 · doc4.xml · derivative · entry 1

Roberts Brandi · CIK 0001516354 · Chief Financial Officer & SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 889,926

Underlying: Common Stock · 889,926 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:23 UTC GrantRestricted Stock Units · Derivative 45,535 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005145 · doc4.xml · derivative · entry 1

Greenleaf Peter · CIK 0001363683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,535

Underlying: Common Stock · 45,535 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:22 UTC GrantRestricted Stock Units · Derivative 79,962 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005139 · doc4.xml · derivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,962

Underlying: Common Stock · 79,962 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:20 UTC
Hood ShanaGeneral Counsel & VP
GrantRestricted Stock Units · Derivative 453,556 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005134 · doc4.xml · derivative · entry 1

Hood Shana · CIK 0001663796 · General Counsel & VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,556

Underlying: Common Stock · 453,556 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:18 UTC
Culley Brian MDirector · CEO and Director
GrantRestricted Stock Units · Derivative 2,368,194 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005130 · doc4.xml · derivative · entry 1

Culley Brian M · CIK 0001310683 · Director · CEO and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,368,194

Underlying: Common Stock · 2,368,194 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document
January 20, 2017 Filed Jan 23, 2017 22:14 UTC
Parsley Edwin L.Chief Medical Officer & SVP
GrantRestricted Stock Units · Derivative 894,572 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-005125 · doc4.xml · derivative · entry 1

Parsley Edwin L. · CIK 0001600117 · Chief Medical Officer & SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 894,572

Underlying: Common Stock · 894,572 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.